Adoptive Immunotherapy for Cancer or Viruses
- 21 March 2014
- journal article
- review article
- Published by Annual Reviews in Annual Review of Immunology
- Vol. 32 (1) , 189-225
Abstract
Adoptive immunotherapy, or the infusion of lymphocytes, is a promising approach for the treatment of cancer and certain chronic viral infections. The application of the principles of synthetic biology to enhance T cell function has resulted in substantial increases in clinical efficacy. The primary challenge to the field is to identify tumor-specific targets to avoid off-tumor, on-target toxicity. Given recent advances in efficacy in numerous pilot trials, the next steps in clinical development will require multicenter trials to establish adoptive immunotherapy as a mainstream technology.Keywords
This publication has 203 references indexed in Scilit:
- Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastomaCancer Immunology, Immunotherapy, 2012
- T Cell Assays and MIATA: The Essential Minimum for Maximum ImpactImmunity, 2012
- Retroviral Integrations in Gene Therapy TrialsMolecular Therapy, 2012
- CARs on Track in the ClinicMolecular Therapy, 2011
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient ColitisMolecular Therapy, 2011
- Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in HumansTransplantation and Cellular Therapy, 2010
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2Molecular Therapy, 2010
- Cell-intrinsic and Vector-related Properties Cooperate to Determine the Incidence and Consequences of Insertional MutagenesisMolecular Therapy, 2009
- Analysis of Lentiviral Vector Integration in HIV+ Study Subjects Receiving Autologous Infusions of Gene Modified CD4+ T CellsMolecular Therapy, 2009
- Expression of IL‐15RA or an IL‐15/IL‐15RA fusion on CD8+ T cells modifies adoptively transferred T‐cell function in cisEuropean Journal of Immunology, 2009